• Subject: Re: After Cum CRT lockups
  • From: Dave Shaw <dshaw1@xxxxxxxxxxx>
  • Date: Fri, 22 May 1998 15:58:49 -0400

-----Original Message-----
From: Carole Houghton <mchcah@dm.deskmedia.com>

>We recently put cum C8069370-01 on on AS/400 V3R7.  Since then we
>have CRT's locking up randomly daily.  We have 3 types of CRT's and
>it happens to all types.  They are all twinax connected to Transition
>hubs.  There is no pattern to the lockups on particular hubs
>either.  We are sure a PTF caused the problem, but IBM says removing
>the PTF will just cause it to happen again when we go to 4.2 (in the
>next few weeks.)  Cancelling the job will get the CRT back up again,
>but it is driving us crazy.  Has anyone else had this happen?  We
>have calls in to all of the CRT manufacturer's (Memorex/Telex, I/O
>and Idea)  Any ideas?

That sounds suspiciously like the symptoms supposedly resolved by the recent
HIPER PTF SF43719 for V3R7.  If so, I believe there is a V4R2 equivalent,
but I don't have it handy.  We've been having this problem happen
intermittently to both terminals and Client Access 5250 displays since V3R6,
and are hoping this PTF is the fix for it (our application window isn't
until the 31st).  I hope this helps you.

Dave Shaw, General Nutrition, Greenville, SC (just down the road from BMW -
Bubba Makes Wheels :)
The opinions expressed may not be my employer's unless I'm sufficiently

| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com

This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].